Andrew Olaye

682 total citations
13 papers, 475 citations indexed

About

Andrew Olaye is a scholar working on Physiology, Public Health, Environmental and Occupational Health and Epidemiology. According to data from OpenAlex, Andrew Olaye has authored 13 papers receiving a total of 475 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Physiology, 4 papers in Public Health, Environmental and Occupational Health and 3 papers in Epidemiology. Recurrent topics in Andrew Olaye's work include Lysosomal Storage Disorders Research (7 papers), Health Systems, Economic Evaluations, Quality of Life (3 papers) and Cytomegalovirus and herpesvirus research (2 papers). Andrew Olaye is often cited by papers focused on Lysosomal Storage Disorders Research (7 papers), Health Systems, Economic Evaluations, Quality of Life (3 papers) and Cytomegalovirus and herpesvirus research (2 papers). Andrew Olaye collaborates with scholars based in United Kingdom, Germany and United States. Andrew Olaye's co-authors include Kevin M. Shakesheff, Abraham J. Domb, Marina Sokolsky‐Papkov, C Knight, Mohit Jain, Regina Leadley, Kate Misso, Jim McGill, Jos Kleijnen and Lock Hock Ngu and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Advanced Drug Delivery Reviews.

In The Last Decade

Andrew Olaye

12 papers receiving 466 citations

Peers

Andrew Olaye

BIOMA

PHYSI

SURGE

Sung Bo Sim South Korea

Jacob Babu United States

Justin Lowenthal United States

Zhonglan Tang Japan

Siyeon Park United States

William R. Humphrey United States

E Fournier France

Xinquan Jiang China

Beom Kang Huh South Korea

Xiuhong Huang China

Sung Bo Sim South Korea

Andrew Olaye

134 ×0.6

BIOMA

145 ×0.8

72 ×0.9

PHYSI

65 ×0.9

154 ×2.3

SURGE

Citations per year, relative to Andrew Olaye Andrew Olaye (= 1×) peers Sung Bo Sim

Countries citing papers authored by Andrew Olaye

Since Specialization

Citations

This map shows the geographic impact of Andrew Olaye's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Olaye with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Olaye more than expected).

Fields of papers citing papers by Andrew Olaye

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew Olaye. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Olaye. The network helps show where Andrew Olaye may publish in the future.

Co-authorship network of co-authors of Andrew Olaye

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew Olaye. A scholar is included among the top collaborators of Andrew Olaye based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew Olaye. Andrew Olaye is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Specchio, Nicola, Paul Gissen, Emily de los Reyes, et al.. (2024). Exploring concurrent validity of the CLN2 Clinical Rating Scale: Comparison to PedsQL using cerliponase alfa clinical trial data. PLoS ONE. 19(5). e0302382–e0302382. 2 indexed citations

Bean, Karen, Simon Jones, Anupam Chakrapani, et al.. (2024). Exploring the Cost-Effectiveness of Newborn Screening for Metachromatic Leukodystrophy (MLD) in the UK. International Journal of Neonatal Screening. 10(3). 45–45.

Armstrong, Nigel, Andrew Olaye, Caro Noake, & Francis Pang. (2023). A systematic review of clinical effectiveness and safety for historical and current treatment options for metachromatic leukodystrophy in children, including atidarsagene autotemcel. Orphanet Journal of Rare Diseases. 18(1). 248–248. 5 indexed citations

Gissen, Paul, Nicola Specchio, Andrew Olaye, et al.. (2021). Investigating health-related quality of life in rare diseases: a case study in utility value determination for patients with CLN2 disease (neuronal ceroid lipofuscinosis type 2). Orphanet Journal of Rare Diseases. 16(1). 217–217. 10 indexed citations

Jones, Simon, James Davison, Peter D. Mooney, et al.. (2021). Demographic and clinical characteristics of patients with metachromatic leukodystrophy in the United Kingdom: Interim results from an observational real-world study. Molecular Genetics and Metabolism. 132(2). S53–S53. 2 indexed citations

Moro, Domenico, Michael Schlander, Harry Telser, et al.. (2021). Evaluating discrete choice experiment willingness to pay [DCE-WTP] analysis and relative social willingness to pay [RS-WTP] analysis in a health technology assessment of a treatment for an ultra-rare childhood disease [CLN2]. Expert Review of Pharmacoeconomics & Outcomes Research. 22(4). 581–598. 4 indexed citations

Nafees, Beenish, et al.. (2020). PRO131 A Societal Utility Study to Elicit Values for Stages of Metachromatic Leukodystrophy (MLD) in the United Kingdom. Value in Health. 23. S713–S713. 3 indexed citations

Schulz, Angela, Mohit Jain, Thomas Butt, et al.. (2020). The Challenges of Living with and Caring for a Child or Children Affected by Neuronal Ceroid Lipofuscinosis Type 2 Disease: In-Depth Family Surveys in the United Kingdom and Germany. SHILAP Revista de lepidopterología. 8. 6 indexed citations

Olaye, Andrew, et al.. (2018). Economic Modeling Considerations for Rare Diseases. Value in Health. 21(5). 515–524. 40 indexed citations

10.

Schlander, Michael, Harry Telser, Oriol Solà-Morales, et al.. (2018). PD49 Social Preferences In HTA: A Pilot Analysis In CLN2 Disease. International Journal of Technology Assessment in Health Care. 34(S1). 146–147. 1 indexed citations

11.

Lampe, Christina, et al.. (2015). Relationship Between Patient-Reported Outcomes and Clinical Outcomes in Patients With Morquio A Syndrome. SHILAP Revista de lepidopterología. 3. 4077969778–4077969778. 10 indexed citations

12.

Leadley, Regina, Shona Lang, Kate Misso, et al.. (2014). A systematic review of the prevalence of Morquio A syndrome: challenges for study reporting in rare diseases. Orphanet Journal of Rare Diseases. 9(1). 173–173. 66 indexed citations

13.

Sokolsky‐Papkov, Marina, et al.. (2007). Polymer carriers for drug delivery in tissue engineering. Advanced Drug Delivery Reviews. 59(4-5). 187–206. 326 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact